Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease

2005 ◽  
Vol 53 (3) ◽  
pp. 724-729 ◽  
Author(s):  
Xin Li ◽  
Wei Huang ◽  
Thomas E. Yankeelov ◽  
Alina Tudorica ◽  
William D. Rooney ◽  
...  
Keyword(s):  
Breast Disease ◽  
Tracking Data ◽  
Bolus Tracking ◽  
Malignant Breast ◽  
Contrast Reagent ◽  
Shutter Speed

Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.

Radiology ◽  
1997 ◽  
Vol 205 (1) ◽  
pp. 214-220 ◽  
Author(s):  
H M Fenlon ◽  
N C Phelan ◽  
P O'Sullivan ◽  
S Tierney ◽  
T Gorey ◽  
...  
Keyword(s):  
Mr Imaging ◽  
Breast Disease ◽  
Contrast Enhanced ◽  
Malignant Breast

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease

1994 ◽  
Vol 25 (11) ◽  
pp. 1228-1233 ◽  
Author(s):  
Elina T. Eriksson ◽  
Hendrik Schimmelpenning ◽  
Ulla Aspenblad ◽  
Anders Zetterberg ◽  
Gert U. Auer
Keyword(s):  
Dna Content ◽  
Nuclear Dna ◽  
P53 Protein ◽  
Nuclear Dna Content ◽  
Breast Disease ◽  
Mutant P53 ◽  
Immunohistochemical Expression ◽  
Malignant Breast

A quantitative analysis of the spatial relationships of grouped microcalcifications demonstrated on xeromammography in benign and malignant breast disease

1988 ◽  
Vol 61 (721) ◽  
pp. 21-25 ◽  
Author(s):  
David M. Hansell ◽  
Julie C. Cooke ◽  
Colin A. Parsons ◽  
Stephen H. Evans ◽  
David R. Dance ◽  
...  
Keyword(s):  
Quantitative Analysis ◽  
Breast Disease ◽  
Spatial Relationships ◽  
Malignant Breast

SERUM LEVELS OF INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN‐3 IN BENIGN AND MALIGNANT BREAST DISEASE

1999 ◽  
Vol 69 (7) ◽  
pp. 495-500 ◽  
Author(s):  
I. M. Holdaway ◽  
B. H. Mason ◽  
A. E. Lethaby ◽  
V. Singh ◽  
J. E. Harman ◽  
...  
Keyword(s):  
Growth Factor ◽  
Binding Protein ◽  
Serum Levels ◽  
Breast Disease ◽  
Insulin Like Growth Factor ◽  
Factor Binding ◽  
Malignant Breast

Neopterin, Catalase and Superoxide Dismutase in Females with Benign and Malignant Breast Tumors

Pteridines ◽  
2007 ◽  
Vol 18 (1) ◽  
pp. 132-138 ◽  
Author(s):  
Osman Yuksel ◽  
Tevfik Tolga Sahin ◽  
Gozde Girgin ◽  
Hande Sipahi ◽  
Kursat Dikmen ◽  
...  
Keyword(s):  
Superoxide Dismutase ◽  
High Performance ◽  
Breast Tumors ◽  
Breast Disease ◽  
Control Group ◽  
Sod Activity ◽  
Neopterin Level ◽  
Malignant Breast ◽  
The Mean ◽  
Urinary Neopterin

Abstract The aim of the present study was to evaluate the relationship between the levels of neopterin among patients with benign and malignant breast disease and the relation with the stage of the malignant process. In this study, neopterin concentrations and enzyme activities of superoxide dismutase (SOD) and catalase (CAT) were determined in malign (n=30) and benign breast tumor patients (n=30) by high performance liquid chromatographic and spectrophotometric methods, respectively. Results were compared with a healthy control group (n=20). The correlations between neopterin, CAT and SOD were also evaluated in controls and patients. Urinary neopterin level of the control group was (mean value ± S.D.) 128.6 ± 64.6 μmol/mol creatinine. Neopterin concentrations in patients with breast malignancy were 153.6 ± 71.2 μmol/mol creatinine and 107.8 ± 32.1 μmol/mol creatinine in benign disorders patients. The mean neopterin level in the benign group was found to be statistically different from the malign tumor group (p = 0.039). SOD and CAT activities in controls were found as 3.57 ± 0.84 U/mg protein and 2.19 ± 0.20 U/mg protein, respectively. In patients with malignancy, the SOD activity was 3.84 ± 0.73 U/mg protein while CAT activity was 1.03 ± 0.13 U/mg protein. Patients with benign breast disorders, SOD activity was 4.09 ± 1.00 U/mg protein and CAT activity was 1.02 ± 0.18 U/mg protein. Whereas SOD activity did not differ between the groups of patients and controls, the mean catalase level in the control group was higher than in the benign and malign tumor groups (both p <0.001). Urinary neopterin concentration seems to be an important and useful biomarker in diagnosis of breast tumors in clinical practice.

Mammoscintigraphy with Tc-99m sestamibi in the evaluation of benign and malignant breast disease

The Breast ◽  
1999 ◽  
Vol 8 (1) ◽  
pp. 40-43 ◽  
Author(s):  
L. Lantsberg ◽  
B. Kirshtein ◽  
S. Lantsberg ◽  
M.R. Quastel
Keyword(s):  
Breast Disease ◽  
Malignant Breast

scholarly journals Spectrum of Breast Diseases in Females- a 10 years study

2018 ◽  
Vol 9 (1) ◽  
pp. 10-12
Author(s):  
Shakera Ahmed ◽  
Sami Ahmad ◽  
Nadim Ahmed ◽  
Nur Mohommad Sayed Bin Aziz
Keyword(s):  
Benign Breast Disease ◽  
Breast Disease ◽  
Breast Diseases ◽  
Historical Cohort ◽  
Female Patients ◽  
Benign Breast Diseases ◽  
Fibrocystic Change ◽  
Malignant Breast ◽  
The Common ◽  
Set Up

Objective: To determine the frequency of various breast diseases in female patients.Methodology: This is a prospective (historical)cohort study of female patients from 18 to 55 years of age visiting a female surgeon with breast problems. The study was conducted at Chittagong Metropoliton Hospital and CSCR Hospital in Chittagong over a period of 10 years starting from July 2007 to June 2017. All female patients visiting with breast problems were included in the study, excluding the patients of below 18 years and above 55 years. The findings were tabulated in excel sheet and analyzed for the frequency of each lesion.Results: A total of 3555 patients were included in the study. Benign breast disease (BBD) was much more common than the malignant breast disease which was 3.49% (124/3555) of all breast diseases. Fibroadenoma was the most common benign breast disease, seen in 32.26%(1147/3555) of patients followed by mastalgia, seen in 24.22%(861) patients. The next common breast disease is fibrocystic change in 18.80%(668/3555) patients.Conclusion: Breast diseases, both benign and malignant are the common problems of female. But benign breast diseases are much more common than the malignant diseases. Fibroadenoma is the commonest of all benign breast diseases in our set up. Mastalgia and fibrocystic changes are the next two common diseases.J Shaheed Suhrawardy Med Coll, June 2017, Vol.9(1); 10-12

22. Scintimammography using 99Tcm-tetrofosmin in the evaluation of benign and malignant breast disease

1996 ◽  
Vol 17 (4) ◽  
pp. 296
Author(s):  
H. M. Fenlon ◽  
N. Phelan ◽  
A. Adams ◽  
J. T. Ennis
Keyword(s):  
Breast Disease ◽  
Malignant Breast
Sign in / Sign up

Export Citation Format

Share Document